capivasertib

Ligand id: 7709

Name: capivasertib

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 7
Hydrogen bond donors 4
Rotatable bonds 7
Topological polar surface area 120.16
Molecular weight 428.17
XLogP 2.44
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
As of October 2018 capivasertib is being evaluated in Phase 1 and 2 clinical trials in patients with various types of advanced solid malignancies. Click here to link to ClinicalTrials.gov's full list of capivasertib trials.